Literature DB >> 17215582

Effect of dietary chromium on resistance artery function and nitric oxide signaling in the sucrose-fed spontaneously hypertensive rat.

Melanie A Kopilas1, Lam N T Dang, Hope D I Anderson.   

Abstract

BACKGROUND: Consumption of high-glycemic index foods contributes to the development of hypertension in some patients. Likewise, in spontaneously hypertensive rats (SHR), high sucrose promotes a secondary rise in systolic blood pressure (SBP). Chromium (III) (Cr(3+)) prevents sucrose-induced hypertension, but leaves the basal hypertension that characterizes SHR intact.
METHODS: Since hypertension entails increased peripheral resistance, we compared effects of Cr(3+) on resistance arteries from SHR fed low-glycemic (starch) versus high-glycemic (sucrose) index diets. Subgroups of SHR also received Cr(3+). Structure, stiffness, and vasodilation of mesenteric resistance arteries were studied using pressurized myography.
RESULTS: Sucrose increased SBP in SHR and, exclusively in sucrose-fed SHR, Cr(3+) reduced SBP and augmented acetylcholine or nitroprusside-dependent vasodilation. Neither sucrose nor Cr(3+) affected artery structure or stiffness. Since Cr(3+) enhanced vasodilation, we assessed endothelial NO synthase (eNOS), guanylate cyclase, cGMP-dependent protein kinase (PKG-1alpha and 1beta), and PKG activity by immunoblotting. Sucrose reduced eNOS, PKG-1beta, and PKG activity. Cr(3+) prevented the effects of sucrose on NO signaling.
CONCLUSION: In hypertension exacerbated by high-glycemic index diet, Cr(3+) reduces SBP. The BP-lowering effect of Cr(3+), selectively on sucrose-induced but not basal hypertension in SHR, involves at least in part, improving vasodilatory function vis-à-vis restoration of NO signaling in resistance arteries. Copyright 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17215582     DOI: 10.1159/000098483

Source DB:  PubMed          Journal:  J Vasc Res        ISSN: 1018-1172            Impact factor:   1.934


  7 in total

Review 1.  The Impact of Chromium Supplementation on Blood Pressure: A Systematic Review and Dose-Response Meta‑Analysis of Randomized‑Controlled Trials.

Authors:  Abolfazl Lari; Somaye Fatahi; Mohammad Hassan Sohouli; Farzad Shidfar
Journal:  High Blood Press Cardiovasc Prev       Date:  2021-06-03

2.  Arterial Stiffness and Trace Elements in Apparently Healthy Population- A Cross-sectional Study.

Authors:  Gangapatnam Subrahmanyam; Rama Mohan Pathapati; Krishnan Ramalingam; Selvam Armugam Indira; Katari Kantha; Bhemasen Soren
Journal:  J Clin Diagn Res       Date:  2016-09-01

3.  Effects of chromium picolinate on vascular reactivity and cardiac ischemia-reperfusion injury in spontaneously hypertensive rats.

Authors:  Worku Abebe; Jun Yao Liu; Hereward Wimborne; Mahmood S Mozaffari
Journal:  Pharmacol Rep       Date:  2010 Jul-Aug       Impact factor: 3.024

4.  Long-term metabolic effects of different doses of niacin-bound chromium on Sprague-Dawley rats.

Authors:  N V Perricone; D Bagchi; B Echard; Harry G Preuss
Journal:  Mol Cell Biochem       Date:  2009-12-11       Impact factor: 3.396

5.  Maitake mushroom extracts ameliorate progressive hypertension and other chronic metabolic perturbations in aging female rats.

Authors:  Harry G Preuss; Bobby Echard; Debasis Bagchi; Nicholas V Perricone
Journal:  Int J Med Sci       Date:  2010-06-07       Impact factor: 3.738

6.  A low-carbohydrate/high-fat diet reduces blood pressure in spontaneously hypertensive rats without deleterious changes in insulin resistance.

Authors:  John D Bosse; Han Yi Lin; Crystal Sloan; Quan-Jiang Zhang; E Dale Abel; Troy J Pereira; Vernon W Dolinsky; J David Symons; Thunder Jalili
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-04-19       Impact factor: 4.733

Review 7.  Metabolic Effects of High Glycaemic Index Diets: A Systematic Review and Meta-Analysis of Feeding Studies in Mice and Rats.

Authors:  Grace J Campbell; Alistair M Senior; Kim S Bell-Anderson
Journal:  Nutrients       Date:  2017-06-22       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.